Psychoneuroimmunology. The relationship between stress, immune system and health;Psychische belastung, immunfunktionen und krankheitsentwicklungen. Die psychoneuroimmunologische perspektive

Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz

Volumn 49, Issue 8, 2006, Pages 759-772

  Schulz, K H ^a   Gold, S ^b  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Breast cancer; Infectious diseases; Multiple sclerosis; Psychoneuroimmunology; Stress; Vaccinations; Wound healing

Indexed keywords

BIOLOGICAL MODEL; CHRONIC DISEASE; HUMAN; IMMUNOLOGY; MENTAL STRESS; METHODOLOGY; NEUROLOGIC DISEASE; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL MODEL; PSYCHOPHYSIOLOGY; REVIEW;

CHRONIC DISEASE; HUMANS; MODELS, IMMUNOLOGICAL; MODELS, PSYCHOLOGICAL; NERVOUS SYSTEM DISEASES; PSYCHONEUROIMMUNOLOGY; STRESS, PSYCHOLOGICAL;

EID: 33747049025     PISSN: 14369990     EISSN: 14371588     Source Type: Journal    
DOI: 10.1007/s00103-006-0006-8     Document Type: Review

References (135)

1. McEwen BS (1998) Protective and damaging effects of stress mediators. N Engl J Med 338: 171-179
2. McEwen BS (2004) Protection and damage from acute and chronic stress. Allostasis and allostatic overload and relevance to the pathophysiology of psychiatric disorders. Ann N Y Acad Sci 1032: 1-7
3. Koob GF, LeMoal M (2001) Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 24: 97-129
4. Schulkin J (1999) Corticotropin-releasing hormone signals adversity in both the placenta and the brain: regulation by glucocorticoids and allostatic overload. J Endocrinol 161: 349-356
5. McEwen BS, Seeman T (1999) Protective and damaging effects of mediators of stress. Elaborating and testing the concepts of allostasis and allostatic load. Ann NY Acad Sci 896: 30-47
6. McEwen BS, Wingfield JC (2003) The concept of allostasis in biology and biomedicine. Hormones Behavior 43: 2-15
7. McEwen BS, Wingfield JC (2003) Response to commentaries on the concept of allostasis. Hormones Behavior 43: 28-30
8. Kaplan JR, Petterson K, Manuck SB, Olsson G (1991) Role of sympatho-adrenal medullary activation in the initiation and progression of atheriosclerosis. Circulation 84 [Suppl VI]: VI23-VI32
9. Lupien SJ, McEwen BS (1997) The acute effects of corticosteroids on cognition: integration of animal and human model studies. Brain Res Rev 24: 1-27
10. Sanders VM, Kasprowicz DJ, Kohm AP, Swanson MA (2001) Neurotransmitter receptors on lymphocytes and other lymphoid cells. In: Ader R, Felten DL, Cohen N (eds) Psychoneuroimmunology, Vol 1, 3rd edn. Academic Press, San Diego San Francisco New York Boston London Sydney Tokyo, pp 161-196
11. Schulz KH, Schulz H (1997) Prolaktin und Immunfunktionen. In: Schulz KH, Kugler J, Schedlowski M (Hrsg) Psychoneuroimmunologie. Hans Huber, Bern Göttingen Toronto Seattle, S 294-303
12. Schulz H, Schulz KH (1997) Kurzfristige psychische Belastungen und Immunfunktionen - eine metaanalytische Übersicht. In: Schulz KH, Kugler J, Schedlowski M (Hrsg) Psychoneuroimmunologie. Hans Huber, Bern Göttingen Toronto Seattle, S 21-59
13. Biondi M (2001) Effects of stress on immune functions: an overview. In: Ader R, Felten DL, Cohen N (eds) Psychoneuroimmunology, Vol 2, 3rd edn. Academic Press, San Diego San Francisco New York Boston London Sydney Tokyo, pp 189-226
14. Segerstrom SC, Miller GE (2004) Psychological stress and the human immune system: a meta-analytic study of 30 years of inquiry. Psychol Bull 130: 601-630
15. Haddad JJ, Saade NE, Safieh-Garabedian B (2002) Cytokines and neuro-immune-endocrine interactions: a role for the hypothalamic-pituitary- adrenal revolving axis. J Neuroimmunol 133: 1-19
16. Sapolsky RM, Romero LM, Munck AU (2000) How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr Rev 21: 55-89
17. Webster JI, Tonelli L, Sternberg EM (2002) Neuroendocrine regulation of immunity. Ann Rev Immunol 20: 125-163
18. McEwen BS, Biron CA, Brunson K et al. (1997) Neural-endocrine-immune interactions: The role of adrenocorticoids as modulators of immune function in health and disease. Brain Res Rev 23: 79-133
19. Padgett DA, Glaser R (2003) How stress influences the immune response. Trends Immunol 24: 444-448
20. Capuron L, Ravaud A, Miller AH, Dantzer R (2004) Baseline mood and psychosocial characteristics of patients developing depressive symptoms during interleukin-2and/or interferon-a cancer therapy. Brain Behav Immun 18: 205-213
21. Maier SF (2003) Bi-directional immune-brain communication: implications for understanding stress, pain, and cognition. Brain Behav Immun 17: 69-85
22. Bellinger D, Lorton D, Lubahn C, Felten D (2001) Innervation of lymphoid organs-association of nerves with cells of the immune system and their implications in disease. In: Ader R, Felten DL, Cohen N (eds) Psychoneuroimmunology, Vol. 1. 3rd edn. Academic Press, San Diego San Francisco New York Boston London Sydney Tokyo, pp 55-111
23. Madden KS (2001) Catecholamines, sympathetic nerves and immunity. In: Ader R, Felten DL, Cohen N (eds) Psychoneuroimmunology, Vol. 1. 3rd edn. Academic Press, San Diego San Francisco New York Boston London Sydney Tokyo, pp 197-216
24. Tarkowski E (2001) Impact of brain injury on immune functions. In: Ader R, Felten DL, Cohen N (eds) Psychoneuroimmunology, Vol. 2. 3rd edn. Academic Press, San Diego San Francisco New York Boston London Sydney Tokyo, pp 349-372
25. Konstantinos AP, Sheridan JF (2001) Stress and influenza viral infection: modulation of proinflammatory cytokine responses in the lung. Respir Physiol 128: 71-77
26. Bonneau RH, Padgett DA, Sheridan JF (2001) Psychoneuroimmune interactions in infectious disease: studies in animals. In: Ader R, Felten DL, Cohen N (eds) Psychoneuroimmunology, Vol. 2. 3rd edn. Academic Press, San Diego San Francisco New York Boston London Sydney Tokyo, pp 483-497
27. Cohen S, Tyrrell DA, Smith AP (1991) Psychological stress and susceptibility to the common cold. N Engl J Med 325: 606-612
28. Stone AA et al. (1992) Development of common cold symptoms following experimental rhinovirus infection is related to prior stressful life events. Behav Med 18: 115-120
29. Cohen S, Doyle WJ, Skoner DP et al. (1997) Social ties and susceptibility to the common cold. JAMA 277: 1940-1944
30. Cohen S, Frank E, Doyle WJ et al. (1998) Types of stressors that increase susceptibility to the common cold in healthy adults. Heatlh Psychol 17: 214-223
31. Cohen S, Doyle WJ, Skoner DP (1999) Psychological stress, cytokine production, and severity of upper respiratory illness. Psychosom Med 61: 175-180
32. Halford WP, Gebhardt BM, Carr DJ (1996) Mechanisms of herpes simplex virus type 1 reactivation. J Virol 70: 5051-5060
33. Padgett DA, Sheridan JF, Dorne J et al. (1998) Social stress and the reactivation of latent herpes simplex virus type 1. Proc Natl Acad Sci USA 95: 7231-7235
34. Glaser R, Kiecolt-Glaser JK, Speicher CE, Holliday JE (1985) Stress, loneliness and changes in herpesvirus latency. J Behav Med 8: 249-260
35. Kiecolt-Glaser JK, Garner W, Speicher C et al. (1984) Psychosocial modifiers of immunocompetence in medical students. Psychosom Med 46: 7-14
36. Kiecolt-Glaser JK, Glaser R, Strain EC et al. (1986) Modulation of cellular immunity in medical students. J Behav Med 9: 5-21
37. Glaser R, Kiecolt-Glaser JK, Stout JC et al. (1985) Stress-related impairments in cellular immunity. Psychiatry Res 16: 233-239
38. Kiecolt-Glaser JK, Glaser R, Gravenstein S et al. (1996) Chronic stress alters the immune response to influenza virus vaccine in older adults. Proc Natl Acad Sci USA 93: 3043-3047
39. Vedhara K, Cox NK, Wilcock GK et al. (1999) Chronic stress in elderly carers of dementia patients and antibody response to influenza vaccination. Lancet 353: 627-631
40. Miller GE, Cohen S, Pressman S et al. (2004) Psychological stress and antibody response to influenza vaccination: when is the critical period for stress, and how does it get inside the body? Psychosom Med 66: 215-223
41. Glaser R, Kiecolt-Glaser JK, Bonneau RH et al. (1992) Stress-induced modulation of the immune response to recombinant hepatitis B vaccine. Psychosom Med 54: 22-29
42. Morag M, Morag A, Reichenberg A et al. (1999) Psychological variables as predictors of rubella antibody titers and fatigue - a prospective, double blind study. J Psychiatr Res 33: 389-395
43. Glaser R, Sheridan J, Malarkey WB et al. (2000) Chronic stress modulates the immune response to a pneumococcal pneumonia vaccine. Psychosom Med 62: 804-807
44. Burns VE, Drayson M, Ring C, Carroll D (2002) Perceived stress and psychological well-being are associated with antibody status after meningitis C conjugate vaccination. Psychosom Med 64: 963-970
45. Burns VE, Carroll D, Ring C, Drayson M (2003) Antibody response to vaccination and psychosocial stress in humans: relationships and mechanisms. Vaccine 21: 2523-2534
46. Tracey KJ (2002) The inflammatory reflex. Nature 420: 853-859
47. Kiecolt-Glaser JK, Marucha PT, Malarkey WB et al. (1995) Slowing of wound healing by psychological stress. Lancet 346: 1194-1196
48. Marucha PT, Kiecolt-Glaser JK, Favagehi M (1998) Mucosal wound healing is impaired by examination stress. Psychosom Med 60: 362-365
49. Glaser R, Kiecolt-Glaser JK, Marucha PT et al. (1999) Stress-related changes in proinflammatory cytokine production in wounds. Arch Gen Psychiatry 56: 450-456
50. Padgett DA, Marucha PT, Sheridan JF (1998) Restraint stress slows cutaneous wound healing in mice. Brain Behav Immun 12: 64-73
51. Kiecolt-Glaser JK, Page GG, Marucha PT et al. (1998) Psychological influences on surgical recovery: perspectives from psychoneuroimmunology. Am Psychol 53: 1209-1218
52. Pharoah PDP, Day NE, Duffy S et al.(1997) Family history and the risk of breast cancer: a systemic review and meta-analysis. Int J Cancer 71: 800-809
53. Arver B, Du Q, Chen J et al. (2000) Hereditary breast cancer: a review. Cancer Biol 10: 271-288
54. Claus EB, Schildkraut JM, Thompson WD, Risch NJ (1996) The genetic attributable risk of breast cancer and ovarian cancer. Cancer 77: 2318-2324
55. Bovbjerg DH, Valdimarsdottir HB (2001) Interventions for healthy individuals at familial risk for cancer. In: Baum A, Anderson BL (rfd) Psychosocial interventions for cancer. American Psychological Association, Washington, pp 305-320
56. Cohen M, Klein E, Kuten A et al. (2002) Increased emotional distress in daughters of breast cancer patients is associated with decreased natural killer cytotoxic activity, elevated levels of stress hormones and decreased secretion of TH1 cytokines. Int J Cancer 100: 347-354
57. Gold SM, Zakowski SG, Valdimarsdottir HB, Bovbjerg DH (2003) Stronger endocrine responses after brief psychological stress in women at familial risk of breast cancer. Psychoneuroendocrinol 28: 584-593
58. James GD, Berge-Landry HvH, Valdimarsdottir HB et al. (2004) Urinary catecholamine levels in daily life are elevated in women at familial risk of breast cancer. Psychoneuroendocrinol 29: 831-838
59. Dettenborn L, James GD, van Berge-Landry H et al. (2005) Heightened cortisol responses to daily stress in working women at familial risk for breast cancer. Biol Psychol 69: 167-179
60. Valdimarsdottir HB, Zakowski SG, Gerin W et al. (2002) Heightened psychobiological reactivity to laboratory stressors in healthy women at familial risk of breast cancer. J Behav Med 25: 51-65
61. Touitou Y, Levi F, Bogdan A et al. (1995) Rhythm alteration in patients with metastatic breast cancer. J Cancer Res Clin Oncol 121: 181-188
62. van der Pompe G, Antoni MH, Heijnen CJ (1996) Elevated basal cortisol levels and attenuated ACTH and cortisol responses to a behavioral challenge in women with metastatic breast cancer. Psychoneuroendocrinol 21: 361-374
63. Turner-Cobb JM (2002) Psychological and neuroendocrine correlates of disease progression. Int Rev Neurobiol 52: 353-381
64. Sephton SE, Sapolsky RM, Kraemer HC, Spiegel D (2000) Diurnal cortisol rhythm as a predictor of breast cancer survival. J Natl Cancer Inst 92: 994-1000
65. Bovbjerg DH, Valdimarsdottir HB (1993) Familial cancer, emotional distress, and low natural cytotoxic activity in healthy women. Ann Oncol 4: 745-752
66. Imai K, Matsuyama S, Miyake S et al. (2000) Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population. Lancet 356: 1795-1799
67. Whiteside T, Herberman R (1989) The role of natural killer cells in human disease. Clin Immunol Immunopathol 53: 1483-1503
68. Levy SM, Herberman RB, Maluish AM et al. (1985) Prognostic risk assessment in primary breast cancer by behavioral and immunological parameters. Health Psychol 4: 99-113
69. Levy SM, Herberman RB, Lippman M, d'Angelo T (1987). Correlation of stress factors with sustained depression of Natural Killer Cell Activity and predicted prognosis in patients with breast cancer. J Clin Oncol 5: 348-353
70. Levy S, Herberman R, Lipman M et al. (1991) Immunological and psychosocial predictors of disease recurrence in patients with early stage breast cancer. Behav Med 17: 67-75
71. Ben Eliyahu S (2003) The promotion of tumor metastasis by surgery and stress: immunological basis and implications for psychoneuroimmunology. Brain Behav Immun 17: S27-S36
72. Byrnes Perreira D, Antoni MH, Danielson A et al. (2003) Life stress and cervical squamous intrepithelial lesions in women with human papillomavirus and human immunodeficiency virus. Psychosom Med 65: 427-434
73. Glaser R, Thorn B, Tarr K et al. (1985) Effects of stress on methyltransferase synthesis: an important DNA repair enzyme. Health Psychol 4: 403-412
74. Kiecolt-Glaser JK, Stephens RE, Lipetz PD et al. (1985) Distress and DNA repair in human lymphocytes. J Behav Med 8: 311-320
75. Schulz KH, Schulz H, Schulz O, Kerekjarto M (1998) Krebspatienten und ihre Familien. Wechselseitige Belastung und Unterstützung. Schattauer, Stuttgart
76. Andersen B, Kiecolt-Glaser J, Glaser R (1994) A biobehavioral model of cancer stress and disease course. Am Psychologist 49: 389-404
77. Gamble L, Mason CM, Nelson S (2006) The effects of alcohol on immunity and bacterial infection in the lung. Med Mal Infect 36 (in press)
78. Irwin M (2002) Effects of sleep and sleep loss on immunity and cytokines. Brain Behav Immun 16: 503-512
79. Schulz KH, Szlovak C, Schulz H et al. (1998) Implementierung und Evaluation eines ambulanten bewegungstherapeutischen Rehabilitationsangebotes für Brustkrebspatientinnen. Psychother Psychosom Med Psychol 48: 398-407
80. Schulz KH, Heesen C (2005) Auswirkungen körperlicher Aktivität bei chronisch Kranken. Beispiele aus der Onkologie und der Neurologie. Bundesgesundheitsbl Gesundheitsforschung Gesundheitsschutz 48: 906-913
81. Gold SM, Mohr DC, Huitinga I et al. (2005) The role of stress-response systems for the pathogenesis and progression of MS. Trends Immunol 26: 644-652
82. Mohr DC, Pelletier D (2006) A temporal framework for understanding the effects of stressful life events on inflammation in patients with multiple sclerosis. Brain Behav Immun 20: 27-36
83. Wilder RL (1995) Neuroendocrine-immune system interactions and autoimmunity. Ann Rev Immunol 13: 307-338
84. Sternberg EM, Glowa JR, Smith MA et al. (1992) Corticotropin releasing hormone related behavioural and neuroendocrine response to stress in Lewis and Fischer rats. Brain Res 570: 54-60
85. Mason D, MacPhee I, Antoni F (1990) The role of the neuroendocrine system in determining genetic susceptibility to experimental allergic encephalomyelitis in the rat. Immunol 70: 1-5
86. Kuroda Y, Mori T, Hori T (1994) Restraint stress suppresses experimental allergic encephalomyelitis in Lewis rats. Brain Res Bull 34: 15-17
87. Bartolomucci A, Sacerdote P, Panerai AE et al. (2003) Chronic psychosocial stress-induced down-regulation of immunity depends upon individual factors. J Neuroimmunol 141(1-2): 58-64
88. Michelson D, Stone L, Galliven E et al. (1994) Multiple sclerosis is accociated with alterations in hypothalamic-pituitary-axis function. J Clin Endocrinol Metab 79: 848-853
89. Grasser A, Möller A, Backmund A et al. (1996) Heterogeneity of hypothalamic-pituitary-adrenal system response to a combined dexamethasone-CRH test in multiple sclerosis. Exp Clin Endocrinol Diabetes 104: 31-37
90. Wei T, Lightman SL (1997) The neuroendocrine axis in patients with multiple sclerosis. Brain 120: 1067-1076
91. Purba JS, Raadsheer F, Hofman MA et al. (1995) Increased number of corticotropin releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of patients with multiple sclerosis. Neuroendocrinol 62: 62-70
92. Reder AT, Lowy MT, Meltzer HY, Antel JP (1987) Dexamethasone suppression test abnormalities in multiple sclerosis: relation to ACTH therapy. Neurology 37: 849-853
93. Then Bergh F, Kümpfel T, Trenkwalder C et al. (1999) Dysregulation of the hypothalamo-pituitary-adrenal axis is related to the clinical course of MS. Neurology 53: 772-777
94. Heesen C, Gold SM, Raji A et al. (2002) Cognitive impairment correlates with hypothalamo-pituitary-adrenal axis dysregulation in multiple sclerosis. Psychoneuroendocrinol 27: 505-517
95. Schumann EM, Kümpfel T, Then Bergh F et al. (2002) Activity of the hypothalamic-pituitary-adrenal axis in multiple sclerosis: correlations with gadolineum-enhancing lesions and ventricular volume. Ann Neurol 51: 763-767
96. Frohman EM, Monson NL, Lovett-Racke AE, Racke MK (2001) Autonomic regulation of neuroimmunological responses: implications for multiple sclerosis. J Clin Immunol 21: 61-73
97. Cosentino M, Zaffaroni M, Marino F et al. (2002) Catecholamine production and tyrosine hydroxylase expression in peripheral blood mononuclear cells from multiple sclerosis patients: effect of cell stimulation and possible relevance for activation-induced apoptosis. J Neuroimmunol 133: 233-240
98. Flachenecker P, Reiners KH, Krauser M et al.(2001) Autonomic dysfunction in multiple sclerosis is related to disease activity and progression of disability. Mult Scler 7: 327-324
99. Huitinga I, Erkut ZA, Van Beurden D, Swaab DF (2003) The hypothalamo-pituitary-adrenal axis in multiple sclerosis. Ann NY Acad Sci 992: 118-128
100. Correale J, Gilmore W, Li S et al. (2000) Resistance to glucocorticoid-induced apoptosis in PLP peptide-specific T cell clones from patients with progressive MS. J Neuroimmunol 109: 197-210
101. van Winsen LM, Muris DF, Polman CH et al. (2005) Sensitivity to glucocorticoids is decreased in relapsing remitting multiple sclerosis. J Clin Endocrinol Metab 90: 734-740
102. DeRijk RH, Eskandari F, Sternberg EM (2004) Corticosteroid resistance in a subpopulation of multiple sclerosis patients as measured by ex vivo dexamethasone inhibition of LPS induced IL-6 production. J Neuroimmunol 151: 180-188
103. Karaszewski JW, Reder AT, Maselli R et al. (1990) Sympathetic skin responses are decreased and lymphocyte beta-adrenergic receptors are increased in progressive multiple sclerosis. Ann Neurol 27: 366-372
104. Zoukos Y, Kidd D, Woodroofe MN et al. (1994) Increased expression of high affinity IL-2 receptors and beta-adrenoceptors on peripheral blood mononuclear cells is associated with clinical and MRI activity in multiple sclerosis. Brain 117 (Pt 2): 307-315
105. Zoukos Y, Thomaides TN, Kidd D et al. (2003) Expression of beta2 adrenoreceptors on peripheral blood mononuclear cells in patients with primary and secondary progressive multiple sclerosis: a longitudinal six month study. J Neurol Neurosurg Psychiatry 74: 197-202
106. Heesen C, Gold SM, Sondermann J et al. (2002) Oral terbutaline differentially affects cytokine (IL-10, IL-12, TNF, IFNg) release in multiple sclerosis patients and controls. J Neuroimmunol 132: 189-195
107. Giorelli M, Livrea P, Trojano M (2004) Post-receptorial mechanisms underlie functional disregulation of beta2-adrenergic receptors in lymphocytes from Multiple Sclerosis patients. J Neuroimmunol 155: 143-149
108. Frohman EM, Vayuvegula B, van den Noort S, Gupta S (1988) Norepinephrine inhibits gamma-interferon-induced MHC class II (Ia) antigen expression on cultured brain astrocytes. J Neuroimmunol 17: 89-101
109. De Keyser J, Wilczak N, Leta R, Streetland C (1999) Astrocytes in multiple sclerosis lack beta-2 adrenergic receptors. Neurology 53: 1628-1633
110. Heesen C, Gold SM, Hartmann S et al. (2003) Endocrine and cytokine response to standardized physical stress in patients with multiple sclerosis and healthy controls. Brain Behav Immun 17: 473-481
111. Heesen C, Köhler G, Gross R et al. (2005) Fatigue in multiple sclerosis: altered cardiovascular and cytokine responses to cognitive stress. Mult Scler 11: 51-57
112. Heesen C, Schulz H, Schmidt M et al. (2002) Endocrine and cytokine response to acute psychological stress in multiple sclerosis. Brain Behav Immun 16: 282-287
113. Ackerman KD, Martino M, Heyman R et al. (1998) Stressor-induced alteration of cytokine production in multiple sclerosis patients and controls. Psychosom Med 60: 484-491
114. Fassbender K, Schmidt R, Mossner R et al. (1998) Mood disorders and dysfunction of the hypothalamic-pituitary-adrenal axis in multiple sclerosis: association with cerebral inflammation. Arch Neurol 55: 66-72
115. De Keyser J, Zeinstra E, Wilczak N (2004) Astrocytic beta2-adrenergic receptors and multiple sclerosis. Neurobiol Dis 15: 331-339
116. De Keyser J, Zeinstra E, Mostert J, Wilczak N (2004) Beta2-adrenoceptor involvement in inflammatory demyelination and axonal degeneration in multiple sclerosis. Trends Pharmacol Sci 25: 67-71
117. Kümpfel T, Then Bergh F, Friess E et al. (1999) Dehydroepiandrosterone response to the adrenocorticotropin test and the combined dexamethasone and corticotropin-releasing hormone test in patients with multiple sclerosis. Neuroendocrinol 70: 431-438
118. Huitinga I, Erkut ZA, van Beurden D, Swaab DF (2004) Impaired hypothalamus-pituitary-adrenal axis activity and more severe multiple sclerosis with hypothalamic lesions. Ann Neurol 55: 37-45
119. Gold SM, Raji A, Huitinga I et al. (2005) Hypothalamo-pituitary-adrenal axis hyperactivity predicts disease progression in multiple sclerosis. J Neuroimmunol 165: 186-191
120. Mohr DC, Hart SL, Julian L, et al. (2004) Association between stressful life events and exacerbation in multiple sclerosis: a meta-analysis. BMJ 328:731-735
121. Filippini G, Munari L, Incorvaia B et al. (2003) Interferons in relapsing remitting multiple sclerosis: a systematic review. Lancet 361: 545-552
122. Li J, Johansen C, Bronnum-Hansen H et al. (2004) The risk of multiple sclerosis in bereaved parents. Neurology 62: 726-729
123. Wright RJ, Cohen RT, Cohen S (2005) The impact of stress on the development and expression of atopy. Curr Opin Allergy Clin Immunol 5: 23-29
124. Wright RJ, Rodriguez M, Cohen S (1998) Review of psychosocial stress and asthma: an integrated biopsychosicial approach. Thorax 53: 1066-1074
125. Kop WJ (2003) The integration of cardiovascular behavioral medicine and psychoneuroimmunology: new developments based on converging research fields. Brain Behav Immun 17: 233-237
126. Fahdi IE, Gaddam V, Garza L et al. (2003) Inflammation, infection and atherosclerosis. Brain Behav Immun 17: 238-244
127. Libby P (2002) Inflammation in atherosclerosis. Nature 420: 868-874
128. Dantzer R (2005) Somatization: a psychoneuroimmune perspective. Psycho neuroendocrinology 30: 947-952
129. Dantzer R (2001) Cytokine-induced sickness behavior: where do we stand? Brain Behav Immun 15: 7-24
130. Konsman JP, Parnet P, Dantzer R (2002) Cytokine-induced sickness behavior: mechanisms and implications. Trends Neurosci 25: 154-159
131. Reichenberg A, Yirmiya R, Schuld A et al. (2001) Cytokine-associated emotional and cognitive disturbances in humans. Arch Gen Psychiatry 58: 445-452
132. Capuron L, Dantzer R (2003) Cytokines and depression: the need for a new paradigm. Brain Behav Immun 17 [Suppl 1]: S119-S124
133. Anisman H, Merall Z, Hayley S (2003) Sensitization associated with stressors and cytokine treatments. Brain Behav Immun 17: 86-93
134. Fawzy FI, Kemeny ME, Fawzy NW et al. (1990) A structured psychiatric intervention for cancer patients. II. Changes over time in immunological measures. Arch Gen Psychiatry 47: 729-735
135. Fawzy F, Fawzy N, Hyun C et al. (1993) Malignant melanoma. Effects of an early psychiatric intervention, coping, and affective state on recurrance and survival 6 years later. Arch Gen Psychiatry 50: 681-689